Treatment of periimplant mucositis with PerioChip®.A randomized controlled clinical trial.
Phase 4
Recruiting
- Conditions
- mucositisK05.5Other periodontal diseases
- Registration Number
- DRKS00007821
- Lead Sponsor
- Zentrum für ZahnmedizinKlinik für Präventivzahnmedizin, Parodontologie und Kariologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
• Informed Consent as documented by signature
• Systemically healthy subjects
• At least one dental implant with mucositis in terms of a probing pocket depth less than 5 and bleeding on probing and no obvious bone loss (< 2mm).
• Ability to read and understand the patient inform
Exclusion Criteria
• Patients with untreated periodontitis
• Pregnant or nursing women
• Patients with antibiotic therapy within the last 6 months
• Patients with periimplantitis therapy within the last 3 months
• Subjects with an allergy to or chlorhexidine
• Anti-coagulated patients
•Periimplantitis: probing pocket depth more than 5 mm and obvious bone loss (> 2mm)
•Intake of medical products containing Nystatin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome variable is bleeding-on-probing after 3 and 6 months after Baseline.
- Secondary Outcome Measures
Name Time Method Secondary outcomes: Changes in the bacterial colonization (bacterial tests), a-MMP8 tests indicating the grade of collagen destruction and plaqueindex